Final visit completed in Phase 3 EFZO-FIT clinical trial of efzofitimod
The final participant has completed the last visit as part of EFZO-FIT, a Phase 3 clinical trial testing Atyr Pharma’s experimental treatment efzofitimod, in adults with pulmonary sarcoidosis. Top-line results are expected in the coming months. “Completing this first-ever global Phase 3 and largest interventional study conducted for patients…